
Alentis Therapeutics
Operator of a clinical-stage biopharmaceutical company intended to offer various treatments for cancer and fibrotic diseases. The company develops innovative therapies for the treatment of cancer and ...
Valuation
$0
Share Price
N/A
Total Raised
$362.5M
Last Round
N/A